⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ZVRA News
Zevra Therapeutics, Inc. Common Stock
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zevra Therapeutics, Inc. (ZVRA) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
ZVRA
Zevra Therapeutics (ZVRA) Securities Investigation Notice - Levi & Korsinsky
globenewswire.com
ZVRA
Zevra Therapeutics (ZVRA) Securities Investigation Notice - Levi & Korsinsky
prnewswire.com
ZVRA
Zevra Therapeutics Announces Publication of Four-Year Real-World Data from U.S. Early Access Program Evaluating MIPLYFFA® (arimoclomol) in Niemann-Pick Disease Type C (NPC)
globenewswire.com
ZVRA
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zevra Therapeutics, Inc. (ZVRA) and Encourages Stockholders to Learn More About the Investigation
accessnewswire.com
ZVRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
accessnewswire.com
ZVRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA
accessnewswire.com
ZVRA
Levi & Korsinsky Announces Investigation of Securities Claims Against Zevra Therapeutics, Inc. (ZVRA)
accessnewswire.com
ZVRA
Bronstein, Gewirtz & Grossman, LLC Encourages Zevra Therapeutics, Inc. (ZVRA) Investors to Inquire about Securities Investigation
accessnewswire.com
ZVRA
Zevra Therapeutics, Inc. (ZVRA) Securities Fraud Investigation - Levi & Korsinsky
accessnewswire.com
ZVRA